Oxford University Press

SHERPA: Yellow

People

  1. De Angelis
    De Angelis
  2. Drilon
    Drilon
  3. Motzer
    Motzer
  4. Mellinghoff
    Mellinghoff
  5. Rosenblum
    Rosenblum
  6. Shuman
    Shuman
  7. Dunkel
    Dunkel
  8. Karajannis
    Karajannis
  9. Saltz
    Saltz
  10. Souweidane
    Souweidane

Groups

  1. Department of Medicine (1983)
  2. Solid Tumor Oncology Division (1615)
  3. GSK Faculty (761)
  4. Survivorship Research (635)
  5. Population Sciences Research Program (612)
  6. Epidemiology and Biostatistics (463)
  7. Department of Pathology and Laboratory Medicine (412)
  8. Gastrointestinal Oncology Service (385)
  9. Genitourinary Oncology Service (364)
  10. Tow Center for Developmental Oncology (TCDO) (352)
Search Within
Formats
  1. Journal Article (2093)
  2. Meeting Abstract (2072)
  3. Book Section (179)
  4. Review (88)
  5. Editorial (80)
  6. Guidelines (35)
  7. Correspondence (24)
  8. Book Whole (17)
  9. Conference Paper (15)
  10. Research Letter (9)
Groups
  1. Department of Medicine (1983)
  2. Solid Tumor Oncology Division (1615)
  3. GSK Faculty (761)
  4. Survivorship Research (635)
  5. Population Sciences Research Program (612)
  6. Epidemiology and Biostatistics (463)

More Groups

People
  1. Lisa De Angelis (119)
  2. Alexander Drilon (108)
  3. Robert Motzer (96)
  4. Ingo Mellinghoff (93)
  5. Marc Rosenblum (87)
  6. Stewart Shuman (87)

More People

Years
  1. 2025 (65)
  2. 2024 (304)
  3. 2023 (320)
  4. 2022 (331)
  5. 2021 (323)
  6. 2020 (325)

More Years

Publications
  1. Annals of Oncology (1666)
  2. Neuro-Oncology (845)
  3. JNCI: Journal of the National Cancer Institute (482)
  4. Nucleic Acids Research (210)
  5. Clinical Infectious Diseases (138)
  6. American Journal of Clinical Pathology (105)

More Publications

Results (4612)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Distribution and clinical significance of FGFR alterations in pediatric and AYA gliomas
    Meeting Abstract

    Nobre, L.; Farouk, S.; Larsen, A.; Bennett, J.; Ho, I. C.; Siddaway, R.; Mellinghoff, I.; Perreault, S.; Magimairajan, V.; Larouche, V.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Direct patient outreach in pediatric neurooncology to improve access to genomic profiling – The make-an-impact program
    Meeting Abstract

    Sait, S. F.; O'Donohue, T.; Hill, K.; Stockfish, E.; Giantini-Larsen, A.; Alano, T.; Bale, T.; Rosenblum, M.; Benhamida, J.; Dunkel, I.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Lessons learned from longitudinal care in posterior fossa syndrome
    Meeting Abstract

    Tsetlina, V.; Cassidy, D.; Tenaglia, A. L.; Levin, J.; Tsao, E.; Ibanez, K.
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Isocitrate dehydrogenase 1 inhibition primes group-3 medulloblastomas for cuproptosis
    Meeting Abstract

    Dang, D.; McKolay, J.; Smith, K.; Panwalkar, P.; Sweha, S.; Natarajan, S. K.; Pun, M. J.; Ji, S.; Patel, D.; Animasahun, O.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Clinical and molecular features of high-grade glioma in children and adults with neurofibromatosis type 1: A preliminary analysis
    Meeting Abstract

    Kotch, C.; Solomon, D. A.; Wallace, K.; de Blank, P. M.; Li, Y.; Mbonglou, F.; Reddy, A. T.; Gutmann, D. H.; Piotrowski, A. F.; Fisher, M. J.
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Outcome of patients with recurrent medulloblastoma and ependymoma treated with pembrolizumab, an immune checkpoint inhibitor: A Pediatric Brain Tumor Consortium study (PBTC045)
    Meeting Abstract

    Hwang, E. I.; Kilburn, L. B.; Mitchell, D. A.; Lin, T.; Young-Poussaint, T.; Robinson, G.; Gajjar, A.; Lenzen, A.; Dorris, K.; Robison, N.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Multi-institution analysis of treatment matching status and outcomes in pediatric CNS tumor patients
    Meeting Abstract

    Horowitz, E. J.; Parisi, R.; Rood, G.; Bowden, A.; Byrwa, D.; Patel, R.; Turco, G.; Korones, D.; Andolina, J.; Comito, M.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Enhancement of blood-brain barrier penetration and tumor targeted drug delivery for DMG using a P-selectin targeted nanomedicine approach
    Meeting Abstract

    Li, B. K.; Vaynshteyn, J.; Tylawsky, D.; Vogt, K.; Raziuddin, R.; Ge, Y.; Heller, D. A.; Becher, O.; Raju, G. P.
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • "Tazni": A phase I/II combination trial of tazemetostat with nivolumab and ipilimumab for children with INI1-negative or SMARCA4-deficient tumors (NCT05407441)
    Meeting Abstract

    Yi, J. S.; Czaplinski, J.; Bhushan, K.; Forrest, S. J.; Shukla, N.; Mack, S.; Hong, A.; Strachan, M.; Dubois, S. G.; London, W. B.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • The landscape of gliomas in children, adolescents and young adults reveals insights on gliomagenesis: A Canadian Adolescents and Young Adults Neuro-Oncology Network (CANON) study
    Meeting Abstract

    Bennett, J.; Levine, A.; Nobre, L.; Negm, L.; Chung, J.; Fang, K.; Johnson, M.; Komosa, M.; Krumholtz, S.; Nunes, N. M.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save